Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 3 of 25

RECRUITING NA

Far Red Light to Improve Functioning in PAD

NCT06165016

RECRUITING Phase 2

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

NCT05864534

RECRUITING NA

Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial

NCT05607732

RECRUITING Phase 1

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

NCT05719714

RECRUITING NA

VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain

NCT06336447

RECRUITING NA

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

NCT05987852

RECRUITING NA

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure, Randomized Controlled Trial

NCT06511414

RECRUITING Phase 4

Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion

NCT06123026

RECRUITING NA

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

NCT05802186

RECRUITING NA

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

NCT05990426

RECRUITING NA

Preventing Postpartum Depression in Immigrant Latinas

NCT05873569

RECRUITING

Bowel Dysfunction and HoLEP Outcomes

NCT06688500

RECRUITING Phase 4

Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery

NCT05351229

RECRUITING Phase 2

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

NCT06062498

RECRUITING NA

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

NCT05743517

RECRUITING Phase 3

SMART Exercise for PAD

NCT06032065

RECRUITING Early Phase 1

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

NCT05838599

RECRUITING NA

Perinatal Depression and Adverse Childhood Experiences: Prevention Trial

NCT05795114

RECRUITING Phase 2

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

NCT05878951

RECRUITING Phase 2

Optimizing Outcomes for Young Autistic Children

NCT05926687

RECRUITING

Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

NCT05950438

RECRUITING Early Phase 1

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

NCT05649098

RECRUITING NA

Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off

NCT06346483

RECRUITING NA

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

NCT05702021

RECRUITING Early Phase 1

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

NCT05852041

RECRUITING

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

NCT05898932

RECRUITING NA

Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke

NCT06598150

RECRUITING NA

Well-Mama Community Doula Navigator Study

NCT05179369

RECRUITING NA

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

NCT05744336

RECRUITING Phase 2

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

RECRUITING Phase 3

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

NCT05620784

RECRUITING

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

NCT05873634

RECRUITING Phase 4

Oral Statins and Protection From Hearing Loss

NCT04826237

RECRUITING NA

BEETroot Juice to Reverse Functional Impairment in PAD

NCT05624125

RECRUITING Phase 3

Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

NCT05703178

RECRUITING NA

Diabetes Toolkit at Discharge

NCT05663931

RECRUITING NA

Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM

NCT05678556

RECRUITING NA

My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life

NCT05369429

RECRUITING Phase 2

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

NCT05620771

RECRUITING

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

NCT05671887

RECRUITING

MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

NCT05424783

RECRUITING Phase 2

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

NCT05576896

RECRUITING Phase 4

NPWTi on Closure of Chronic Pressure Sores

NCT05598398

RECRUITING NA

Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making

NCT05111223

RECRUITING Phase 3

Dronabinol After Arthroscopic Surgery

NCT05335252

RECRUITING

Motor rECovery witH eArly imagiNg In STroke

NCT04165616

RECRUITING NA

Training Swallowing Initiation During Expiration

NCT05278039

RECRUITING NA

Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes

NCT04976881

RECRUITING

Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety

NCT06096311

RECRUITING NA

Childhood Activities Nutrition and Development Oversight

NCT05258656

← Previous Page 3 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.